Common medications alter flu virus activity
Several commonly prescribed medications used for completely different illnesses can enhance or reduce the activity of the influenza virus.
Clinical and Molecular Medicine
LOADING CONTENT
New drug combination effective against SARS-CoV-2 infection
The fight against COVID-19 is far from over. A new combination of drugs could help save lives.
Start-up takes NTNU’s Covid technology to new markets and applications
Lybe Scientific, a start-up company based on NTNU research, is entering the market as a provider of high-quality diagnostic solutions – not just for COVID-19 diagnostics, but also other areas such as the common flu and sexually transmitted diseases.
Researchers figure out how cancer cells make lactic acid to survive
For the first time, researchers have shown how cancer cells reprogram themselves to produce lactic acid and to tolerate the acidic environment that exists around tumours. The finding could lead to a whole new direction for treating cancer.
Is it always right to save lives? A radical proposal
In neonatal medicine, there is a grey area where professionals may be uncertain whether it is in the child’s best interests to start life-saving treatment. Without it, the infant dies. But the treatment can also do great harm. One of the foremost duties of medicine is often said to be to “do no harm”. But how much of a burden on the infant is acceptable? At what point is the hope simply too small to justify action?
Mini-brains reveal cause of rare syndromes
The culprit behind a large number of cancerous tumours is known to be a certain protein. Now for the first time, research shows that the same protein is the cause of several rare brain syndromes.
Nordic prize for excellent research awarded to NTNU professor
The Anders Jahre’s Award for Medical Research for young researchers is awarded this year to Professor Barbara van Loon at NTNU. Several previous winners of the main prize have since received the Nobel Prize in Medicine. This includes May-Britt and Edvard Moser at NTNU.
Genetic link between preeclampsia and heart disease
Researchers at NTNU have contributed to the discovery of gene variants in mothers that increase their risk of both preeclampsia and heart disease.
Mini-hearts are similar to human hearts
NTNU master’s student Vanessa Solvang cultivates tiny little beating hearts in the lab. She takes good care of them, weekends included.
Preemies at greater risk for mortality in adulthood
The risk of dying from heart disease, chronic lung disease or diabetes in adulthood is twice as high for preemies —premature infants — as for the general population. Even those who were born just two to three weeks before term have a slightly increased risk.
NTNU researchers have found promising COVID-19 drugs
NTNU researchers are on track to find drug combinations that could help stop the coronavirus across the globe.
Where the starring role is death
Nine hundred people from Trøndelag county have donated their bodies to research when they die. Why do they do it, and what are the bodies actually used for? Come on into the anatomical laboratory at NTNU.
Not enough COVID-19 tests? No problem, we’ll make them!
The story of what happened when a molecular biologist, some engineers and PhDs and postdocs from NTNU and St Olavs Hospital put their heads together to design a completely different kind of coronavirus test.
Trained medical staff can perform safe, effective hernia surgery
Many low and middle-income countries, particularly in sub-Saharan Africa, don’t have enough surgeons to perform vital surgeries, such as groin hernia repairs. Training non-doctor associate clinicians in this procedure provides a safe and effective solution, a new study shows.
Virus might have mutated before it appeared in mink
It’s understandable that the Danes want to be on the safe side and exterminate the mink to stop this variant of the coronavirus, says Andreas Christensen, an associate professor at NTNU.
Perforated bone tissue from too little sugar
Bone marrow cancer is currently an incurable disease that affects about 400 people in Norway every year. Professor Therese Standal at NTNU has now found an important reason for bone destruction in people with this disease.
NTNU’s new COVID-19 test to be used in India and Denmark
The Norwegian University of Science and Technology (NTNU) has signed agreements to deliver as many as one million COVID-19 test kits to DTU, the Technical University of Denmark, and APS LABS, an Indian biotech company. “It is very positive that this technology can now also be useful internationally,” says Bent Høie, Norway’s Minister of Health and Care Services.
Adverse effects from cancer drug trials explained
Certain type of cancer drugs that promote the death of cells can actually be harmful if combined with other treatments that damage our DNA, RNA or proteins, researchers have found.
Better treatment for people with inflammatory bowel disease
Chronic intestinal inflammation requires special individualized treatment. Finding the right treatment for each person may soon become easier.
Combination drug treatments for COVID-19 show promise in cell culture tests
One combination of two drugs was so effective that researchers hope others can begin clinical trials on the drugs now.
New NTNU method for accurately detecting lung cancer
CT screening to detect lung cancer can save lives. The challenge is to find out who should undergo CT scans. A new method more accurately identifies the right individuals in the risk zone.
NTNU establishes a factory to produce coronavirus tests
NTNU researchers recently figured out a whole new method for testing people for the coronavirus. The university is now producing tests on a continuous basis, under the auspices of the Norwegian Directorate of Health. Currently 100 000 tests a day are being manufactured, with production soon likely to be scaled up dramatically.
Norway to start broad-based testing by month’s end using NTNU test kits
Norway’s Ministry of Health and Care Services confirmed Friday that it will roll out coronavirus test kits developed by researchers from NTNU and St Olavs Hospital by the last week of April/early May. The kits will more than triple Norway’s testing capacity during the rollout.
Existing drugs may offer a first-line treatment for coronavirus outbreak
There’s no effective treatment for the coronavirus that causes COVID-19, which was first detected in Wuhan, China. Developing new drugs and vaccines can take years. Existing drugs offer a possible quick response to the potential pandemic.